Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Clemons

Showing results (201-210 of 267) with videos related to

Pageof 27
Sort By:
Breast Cancer Research and Treatment|July 9, 2014
Platinum-based chemotherapy in triple-negative advanced breast cancerCynthia Villarreal-Garza, Daniel Khalaf, Nathaniel Bouganim, et al.
Clinical Breast Cancer|November 6, 2021
Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic ReviewMichelle Bradbury, Brian Hutton, Ana-Alicia Beltran-Bless, et al.
Journal of Bone Oncology|March 8, 2021
Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalationSharon McGee, Mashari AlZahrani, Carol Stober, et al.
Current Oncology (Toronto, Ont.)|March 27, 2024
Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort StudyArif Ali Awan, Deanna Saunders, Gregory Pond, et al.
Breast Cancer Research and Treatment|April 27, 2007
A Phase 2 study of perifosine in advanced or metastatic breast cancerNatasha B Leighl, Susan Dent, Mark Clemons, et al.
Breast Cancer Research and Treatment|March 27, 2015
Erratum to: platinum-based chemotherapy in triple-negative advanced breast cancerCynthia Villarreal-Garza, Daniel Khalaf, Nathaniel Bouganim, et al.
Current Oncology (Toronto, Ont.)|December 23, 2021
Experiences and Perceptions of Older Adults with Lower-Risk Hormone Receptor-Positive Breast Cancer about Adjuvant Radiotherapy and Endocrine Therapy: A Patient SurveyMarie-France Savard, Mashari Jemaan Alzahrani, Deanna Saunders, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 3, 2022
Vasomotor symptoms in early breast cancer-a "real world" exploration of the patient experienceKatherine Marie Cole, Mark Clemons, Mashari Alzahrani, et al.
NEJM Evidence|May 26, 2026
Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast CancerMark Clemons, Carol Stober, Gregory R Pond, et al.
Clinical Breast Cancer|August 25, 2016
Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients-A Systematic ReviewShaan Dudani, Sasha Mazzarello, John Hilton, et al.
Pageof 27

Showing results (201-210 of 267) with videos related to

Sort By:
Pageof 27
Breast Cancer Research and Treatment|July 9, 2014
Platinum-based chemotherapy in triple-negative advanced breast cancerCynthia Villarreal-Garza, Daniel Khalaf, Nathaniel Bouganim, et al.
Clinical Breast Cancer|November 6, 2021
Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic ReviewMichelle Bradbury, Brian Hutton, Ana-Alicia Beltran-Bless, et al.
Journal of Bone Oncology|March 8, 2021
Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalationSharon McGee, Mashari AlZahrani, Carol Stober, et al.
Current Oncology (Toronto, Ont.)|March 27, 2024
Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort StudyArif Ali Awan, Deanna Saunders, Gregory Pond, et al.
Breast Cancer Research and Treatment|April 27, 2007
A Phase 2 study of perifosine in advanced or metastatic breast cancerNatasha B Leighl, Susan Dent, Mark Clemons, et al.
Breast Cancer Research and Treatment|March 27, 2015
Erratum to: platinum-based chemotherapy in triple-negative advanced breast cancerCynthia Villarreal-Garza, Daniel Khalaf, Nathaniel Bouganim, et al.
Current Oncology (Toronto, Ont.)|December 23, 2021
Experiences and Perceptions of Older Adults with Lower-Risk Hormone Receptor-Positive Breast Cancer about Adjuvant Radiotherapy and Endocrine Therapy: A Patient SurveyMarie-France Savard, Mashari Jemaan Alzahrani, Deanna Saunders, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 3, 2022
Vasomotor symptoms in early breast cancer-a "real world" exploration of the patient experienceKatherine Marie Cole, Mark Clemons, Mashari Alzahrani, et al.
NEJM Evidence|May 26, 2026
Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast CancerMark Clemons, Carol Stober, Gregory R Pond, et al.
Clinical Breast Cancer|August 25, 2016
Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients-A Systematic ReviewShaan Dudani, Sasha Mazzarello, John Hilton, et al.
Pageof 27